Cancer Biology & Medicine

|

中国抗癌协会
China
MEDICINE
Frontier Science Journal
英语
钻石OA
T1
SCIE, Scopus, PMC, MEDLINE, DOAJ, Chemical Abstracts, EBSCO, BIOSIS Previews, EMBASE

Publishing Information

/
单盲

Founding year

2004

Publishing Frequency

12

Number of articles per year

91

(2023)

Acceptance Rate

24%

(2023)

Open Access

CC BY

Content

研究型论文; 综述
/
自由来稿
Cancer Biology & Medicine (CBM) is a peer-reviewed open-access journal sponsored by China Anti-cancer Association (CACA) and Tianjin Medical University Cancer Institute and Hospital. The journal monthly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: Cancer genetics Cancer and stem cell biology Molecular and clinical immunology Cancer prevention and epidemiology Cancer biomarkers Radiation oncology Oncology clinical trials Mechanisms of drug sensitivity and resistance Targeted therapy and immunotherapy Multidisciplinary treatment and personalized medicine